HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chanhee Chae Selected Research

heyneanol A

10/2006Potent inhibition of Lewis lung cancer growth by heyneanol A from the roots of Vitis amurensis through apoptotic and anti-angiogenic activities.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chanhee Chae Research Topics

Disease

31Viremia
07/2021 - 10/2012
25Infections
04/2022 - 03/2003
13Porcine Reproductive and Respiratory Syndrome (PRRS)
02/2021 - 10/2011
8Neoplasms (Cancer)
10/2016 - 05/2004
8Lung Neoplasms (Lung Cancer)
10/2016 - 10/2006
7Carcinogenesis
10/2016 - 09/2004
6Pneumonia (Pneumonitis)
04/2022 - 04/2009
5Wasting Syndrome (Wasting Disease)
07/2014 - 05/2003
3Interstitial Lung Diseases (Interstitial Lung Disease)
01/2020 - 08/2014
3Coinfection
04/2019 - 11/2014
3Weight Gain
05/2015 - 07/2013
3Hypersensitivity (Allergy)
02/2013 - 07/2012
2Respiratory Tract Diseases (Respiratory Tract Disease)
07/2020 - 04/2019
2Fever (Fevers)
09/2015 - 05/2009
2Adenocarcinoma
01/2015 - 07/2012
2Orthomyxoviridae Infections
10/2011 - 05/2009
2Diarrhea
07/2004 - 01/2002
1Chromosome Aberrations (Chromosome Abnormalities)
01/2022
1Virus Diseases (Viral Diseases)
07/2021
1Communicable Diseases (Infectious Diseases)
01/2017
1Ureteral Obstruction
01/2016
1Inflammation (Inflammations)
11/2015
1Non-alcoholic Fatty Liver Disease
01/2015
1Asthma (Bronchial Asthma)
11/2013
1Human Influenza (Influenza)
06/2011
1Insulin Resistance
01/2010
1Obesity
01/2010
1Glucose Intolerance
01/2010
1Fatty Liver
01/2010
1Pleuropneumonia
10/2009
1Lewis Lung Carcinoma
10/2006

Drug/Important Bio-Agent (IBA)

39VaccinesIBA
02/2022 - 07/2011
14AntigensIBA
07/2021 - 03/2013
12InterferonsIBA
01/2020 - 10/2012
9Neutralizing AntibodiesIBA
10/2019 - 10/2012
6Subunit VaccinesIBA
04/2021 - 03/2014
6AntibodiesIBA
04/2021 - 10/2012
6AerosolsIBA
10/2016 - 11/2011
5Combined VaccinesIBA
04/2022 - 10/2020
5Small Interfering RNA (siRNA)IBA
10/2016 - 11/2011
4Proteins (Proteins, Gene)FDA Link
01/2022 - 05/2009
4Formaldehyde (Formol)FDA Link
07/2014 - 05/2003
4ParaffinIBA
07/2014 - 05/2003
4DNA (Deoxyribonucleic Acid)IBA
02/2014 - 05/2003
3SpermineIBA
10/2016 - 11/2011
3Phosphates (Orthophosphate)IBA
01/2015 - 01/2013
3Interferon-gamma (Interferon, gamma)IBA
03/2014 - 07/2012
2Liposomes (Liposome)IBA
04/2018 - 07/2017
2Glycerol (Glycerine)FDA LinkGeneric
10/2016 - 01/2012
2Immunoglobulin G (IgG)IBA
11/2014 - 10/2012
2Monoclonal AntibodiesIBA
07/2014 - 07/2009
2SymportersIBA
01/2014 - 01/2013
2SodiumIBA
01/2014 - 01/2013
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2009 - 04/2009
1bisphenol FIBA
01/2022
1Viral DNAIBA
01/2021
1DNA ProbesIBA
02/2020
1Codon (Codons)IBA
01/2020
1Protein Subunit VaccinesIBA
04/2018
1IsotopesIBA
01/2017
1dibenzo(1,4)dioxinIBA
01/2017
1furanIBA
01/2017
1Polychlorinated Dibenzodioxins (TCDD)IBA
01/2017
1FucoseIBA
02/2016
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
01/2016
1PolyethyleneimineIBA
01/2016
1Sorbitol (Yal)FDA Link
01/2016
1chitobionic acidIBA
01/2016
1titanium dioxide (Titania)FDA Link
11/2015
1Carbon Nanotubes (Carbon Nanotube)IBA
01/2015
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2014
1UbiquitinIBA
02/2014
1Nuclear Antigens (Extractable Nuclear Antigens)IBA
02/2014
1OvalbuminIBA
11/2013
1Therapeutic UsesIBA
11/2013
1nasIBA
03/2013
1Beclin-1IBA
07/2012
1RNA (Ribonucleic Acid)IBA
01/2012
1EstersIBA
11/2011
12-(9-oxo)nonanoyl glycerolIBA
11/2011
1Peroxidase (Myeloperoxidase)IBA
10/2011
1Viral ProteinsIBA
06/2011
1Messenger RNA (mRNA)IBA
06/2011
1Insulin (Novolin)FDA Link
01/2010
1Glucose (Dextrose)FDA LinkGeneric
01/2010
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2010
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
01/2010
1Virulence Factors (Pathogenicity Factors)IBA
10/2009
1CytokinesIBA
04/2009
1Interleukin-6 (Interleukin 6)IBA
04/2009
1Interleukin-1 (Interleukin 1)IBA
04/2009
1CaspasesIBA
10/2006
1ResveratrolIBA
10/2006
1Caspase 3 (Caspase-3)IBA
10/2006

Therapy/Procedure

3Therapeutics
10/2016 - 11/2011
2Drug Therapy (Chemotherapy)
02/2014 - 11/2012
1Laser Therapy (Surgery, Laser)
01/2015
1Injections
11/2013
1Radiotherapy
07/2012
1Chemoprevention
10/2006